Maxim Group upgraded shares of Medicus Pharma (CVE:MDC – Free Report) to a strong-buy rating in a report released on Thursday morning,Zacks.com reports.
Separately, D Boral Capital upgraded shares of Medicus Pharma to a “strong-buy” rating in a research note on Monday, April 14th.
Read Our Latest Analysis on Medicus Pharma
Medicus Pharma Price Performance
Featured Stories
- Five stocks we like better than Medicus Pharma
- How to Calculate Inflation Rate
- GlobalFoundries Stock Hits Bottom: Is a Rebound Coming?
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Here’s The Reason Goldman Sachs Is Bullish On MercadoLibre Stock
- ESG Stocks, What Investors Should Know
- Analyst-Favorite Bitcoin Miner CleanSpark: Worth the Hype?
Receive News & Ratings for Medicus Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicus Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
